Gambaran Umum
Alector, Inc., based in the United States, operates primarily in the biotechnology industry, focusing on the development of therapies that harness the human immune system to combat neurodegeneration. The company's innovative approach involves targeting immune dysregulation in the brain, a key factor in neurological disorders such as Alzheimer's disease and frontotemporal dementia. Alector's pipeline includes several key projects like AL001 and AL101, both designed to enhance progranulin levels, thereby potentially modifying the course of neurodegenerative diseases. These projects are in various stages of clinical development, underlining the company's commitment to addressing some of the most challenging conditions affecting the central nervous system.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Alector, Inc. per 2025 Jun 30 adalah 81.13 MM.
- Nilai operating income untuk Alector, Inc. per 2025 Jun 30 adalah -132.31 MM.
- Nilai net income untuk Alector, Inc. per 2025 Jun 30 adalah -115.29 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 81.13 | -132.31 | -115.29 |
2025-03-31 | 88.34 | -143.78 | -123.44 |
2024-12-31 | 100.56 | -142.79 | -119.05 |
2024-09-30 | 61.51 | -183.00 | -158.41 |
2024-06-30 | 55.27 | -187.35 | -160.66 |
2024-03-31 | 96.41 | -145.33 | -120.61 |
2023-12-31 | 97.06 | -151.74 | -130.39 |
2023-09-30 | 96.31 | -159.72 | -141.38 |
2023-06-30 | 102.06 | -156.89 | -143.06 |
2023-03-31 | 125.69 | -143.83 | -134.55 |
2022-12-31 | 133.62 | -137.83 | -133.31 |
2022-09-30 | 133.17 | -138.12 | -136.49 |
2022-06-30 | 300.73 | 35.95 | 36.26 |
2022-03-31 | 227.45 | -28.85 | -28.77 |
2021-12-31 | 207.09 | -37.36 | -36.33 |
2021-09-30 | 197.94 | -34.39 | -32.90 |
2021-06-30 | 21.43 | -214.47 | -212.20 |
2021-03-31 | 18.04 | -205.73 | -202.38 |
2020-12-31 | 21.10 | -195.17 | -190.23 |
2020-09-30 | 22.25 | -173.60 | -168.58 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk Alector, Inc. pada 2025 Jun 30 adalah -1.17.
- laba per saham yang terdilusi untuk Alector, Inc. pada 2025 Jun 30 adalah -1.17.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | -1.17 | -1.17 |
2025-03-31 | -1.26 | -1.27 |
2024-12-31 | -1.23 | |
2024-09-30 | -1.70 | -1.70 |
2024-06-30 | -1.79 | -1.79 |
2024-03-31 | -1.40 | -1.39 |
2023-12-31 | -1.56 | |
2023-09-30 | -1.70 | -1.70 |
2023-06-30 | -1.72 | -1.72 |
2023-03-31 | -1.63 | -1.63 |
2022-12-31 | -1.62 | |
2022-09-30 | -1.66 | -1.66 |
2022-06-30 | 0.44 | 0.45 |
2022-03-31 | -0.35 | -0.35 |
2021-12-31 | -0.45 | |
2021-09-30 | -0.41 | -0.42 |
2021-06-30 | -2.68 | -2.68 |
2021-03-31 | -2.57 | -2.57 |
2020-12-31 | -2.45 | |
2020-09-30 | -2.25 | -2.24 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Alector, Inc. per 2025 Jun 30 adalah -215.59 MM.
- Nilai cash from investing activities untuk Alector, Inc. per 2025 Jun 30 adalah 203.21 MM.
- Nilai kas dari aktivitas pendanaan untuk Alector, Inc. per 2025 Jun 30 adalah 9.91 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -215.59 | 203.21 | 9.91 |
2025-03-31 | -229.34 | 184.63 | 10.43 |
2024-12-31 | -229.91 | 107.13 | 81.54 |
2024-09-30 | -220.95 | 83.80 | 72.34 |
2024-06-30 | -216.75 | 60.41 | 72.34 |
2024-03-31 | -196.96 | 1.45 | 72.58 |
2023-12-31 | -184.16 | 101.92 | 2.55 |
2023-09-30 | -187.02 | 102.23 | 2.60 |
2023-06-30 | -189.53 | 145.80 | 3.08 |
2023-03-31 | -203.97 | -58.21 | 3.11 |
2022-12-31 | -20.33 | -159.01 | 4.51 |
2022-09-30 | -20.67 | -324.15 | 12.52 |
2022-06-30 | 473.44 | -453.73 | 26.85 |
2022-03-31 | 486.33 | -171.32 | 28.90 |
2021-12-31 | 298.55 | -49.66 | 30.30 |
2021-09-30 | 300.16 | 108.64 | 22.75 |
2021-06-30 | -185.72 | 210.71 | 8.22 |
2021-03-31 | -187.11 | 129.37 | 7.53 |
2020-12-31 | -166.73 | -105.05 | 232.11 |
2020-09-30 | -147.90 | -86.55 | 232.45 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk Alector, Inc. pada 2025 Jun 30 adalah 1.47.
- p/tbv untuk Alector, Inc. pada 2025 Jun 30 adalah 1.47.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 1.47 | 1.47 | |
2025-03-31 | 1.01 | 1.01 | |
2024-12-31 | 1.42 | 1.42 | |
2024-09-30 | -2.98 | 3.18 | 3.18 |
2024-06-30 | -3.62 | 2.44 | 2.44 |
2024-03-31 | 4.30 | 4.30 | |
2023-12-31 | -4.75 | 4.14 | 4.14 |
2023-09-30 | -3.80 | 2.77 | 2.77 |
2023-06-30 | -3.63 | 2.67 | 2.67 |
2023-03-31 | -3.86 | 2.40 | |
2022-12-31 | 3.01 | 3.01 | |
2022-09-30 | 2.71 | 2.71 | |
2022-06-30 | 3.13 | 3.13 | |
2022-03-31 | -32.20 | 3.89 | 3.89 |
2021-12-31 | -50.99 | 4.99 | 4.99 |
2021-09-30 | -8.70 | 10.00 | 10.00 |
2021-06-30 | |||
2021-03-31 | -3.94 | 3.50 | 3.50 |
2020-12-31 | -4.17 | 2.96 | 2.96 |
2020-09-30 | -4.70 | 2.56 | 2.56 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Alector, Inc. pada 2025 Jun 30 adalah -1.11.
- EBIT (3 tahun) / EV untuk Alector, Inc. pada 2025 Jun 30 adalah -1.26.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -1.11 | -1.26 |
2025-03-31 | -1.14 | -1.17 |
2024-12-31 | -1.19 | -1.05 |
2024-09-30 | -0.37 | -0.33 |
2024-06-30 | -0.32 | -0.25 |
2024-03-31 | -0.25 | -0.19 |
2023-12-31 | -0.24 | -0.18 |
2023-09-30 | -0.34 | -0.25 |
2023-06-30 | -0.45 | -0.35 |
2023-03-31 | -0.36 | -0.33 |
2022-12-31 | -0.23 | -0.19 |
2022-09-30 | 0.06 | -0.09 |
2022-06-30 | -0.07 | -0.34 |
2022-03-31 | -0.04 | -0.14 |
2021-12-31 | -0.03 | -0.09 |
2021-09-30 | -0.12 | -0.09 |
2021-06-30 | ||
2021-03-31 | -0.29 | -0.19 |
2020-12-31 | -0.26 | -0.16 |
2020-09-30 | -0.24 | -0.14 |
Efektivitas Manajemen
- roa untuk Alector, Inc. pada 2025 Jun 30 adalah -0.22.
- roe untuk Alector, Inc. pada 2025 Jun 30 adalah -0.82.
- roic untuk Alector, Inc. pada 2025 Jun 30 adalah -0.91.
- croic untuk Alector, Inc. pada 2025 Jun 30 adalah -0.25.
- ocroic untuk Alector, Inc. pada 2025 Jun 30 adalah -1.69.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.22 | -0.82 | -0.91 | -0.25 | -1.69 |
2025-03-31 | -0.19 | -0.67 | -0.70 | -0.24 | -1.36 |
2024-12-31 | -0.25 | -1.18 | -1.03 | -0.42 | -1.44 |
2024-09-30 | -0.24 | -0.99 | -0.86 | -0.45 | -1.16 |
2024-06-30 | -0.16 | -0.66 | -0.56 | -0.57 | -0.91 |
2024-03-31 | -0.17 | -0.61 | -0.75 | -0.46 | -1.06 |
2023-12-31 | -0.17 | -0.56 | -0.70 | -0.41 | -0.92 |
2023-09-30 | -0.16 | -0.50 | -0.60 | -0.17 | -0.80 |
2023-06-30 | -0.15 | -0.47 | -0.60 | -0.17 | -0.80 |
2023-03-31 | -0.14 | -0.50 | -0.60 | -1.15 | -0.91 |
2022-12-31 | -0.16 | -0.41 | -0.46 | -1.12 | -0.07 |
2022-09-30 | 0.04 | 0.11 | -0.46 | -1.12 | -0.07 |
2022-06-30 | -0.07 | -0.16 | 0.11 | 0.14 | 1.42 |
2022-03-31 | -0.08 | -0.16 | -0.09 | 1.09 | 1.55 |
2021-12-31 | -0.07 | -0.12 | -0.10 | 0.80 | 0.78 |
2021-09-30 | -0.06 | -0.68 | -0.09 | 1.12 | -0.79 |
2021-06-30 | -0.37 | -0.60 | -0.91 | 0.14 | -0.79 |
2021-03-31 | -0.33 | -0.52 | -0.73 | -0.18 | -0.67 |
2020-12-31 | -0.45 | -0.98 | -0.60 | -0.12 | -0.52 |
2020-09-30 | -0.37 | -0.77 | -0.47 | -0.01 | -0.42 |
Gross Margins
- marjin kotor untuk Alector, Inc. pada 2025 Jun 30 adalah -0.97.
- marjin bersih untuk Alector, Inc. pada 2025 Jun 30 adalah -1.40.
- marjin operasi untuk Alector, Inc. pada 2025 Jun 30 adalah -1.63.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | -0.97 | -1.40 | -1.63 |
2025-03-31 | -0.85 | -1.18 | -1.42 |
2024-12-31 | -2.04 | -2.58 | -2.98 |
2024-09-30 | -2.47 | -2.91 | -3.39 |
2024-06-30 | -0.92 | -1.25 | -1.51 |
2024-03-31 | -0.98 | -1.34 | -1.56 |
2023-12-31 | -1.07 | -1.47 | -1.66 |
2023-09-30 | -0.97 | -1.40 | -1.54 |
2023-06-30 | -0.66 | -1.40 | -1.54 |
2023-03-31 | -0.57 | -1.07 | -1.14 |
2022-12-31 | -0.57 | -1.02 | -1.04 |
2022-09-30 | 0.32 | -1.02 | -1.04 |
2022-06-30 | 0.14 | 0.12 | 0.12 |
2022-03-31 | 0.09 | -0.13 | -0.13 |
2021-12-31 | 0.09 | -0.18 | -0.18 |
2021-09-30 | -7.48 | -0.17 | -0.17 |
2021-06-30 | -7.48 | -9.90 | -9.99 |
2021-03-31 | -8.31 | -11.22 | -11.41 |
2020-12-31 | -9.02 | -9.25 | |
2020-09-30 | -5.21 | -7.58 | -7.80 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1653087 |
Grupong Pang-industriya
SIC 2836 - Biological Products, Except Diagnostic Substances (Biotech) |